BLOG

Learn some of the key strategies Altasciences employs to ensure you have the participants you need for your studies.

Get to know Dr. Anahita Keyhani, PhD, Senior Director of Scientific Operations, Mass Spectrometry and Method Development, at Altasciences.

As the COVID-19 pandemic evolves across the globe, the search for effective therapies also continues to gain momentum, including the possibility of repurposing existing medications that may show effectiveness against COVID-19 symptoms.

Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant advantages in preclinical and clinical studies alike. This month's blog includes an overview, and additional information.

Vaccine development is a complex, time-consuming process at the best of times. Now, facing a world-wide pandemic of a novel virus, understanding the science, the regulatory process, and the desire for an immunization solution has never been more crucial.

Get to know Francis Douville, Senior Vice President of Technical Operations at Altasciences' preclinical facility in Seattle, Washington.

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.